Intercept Pharmaceuticals reported $77.59M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 130.71M 3.85M
Acorda Therapeutics ACOR:US $ 33.01M 1.96M
Alnylam Pharmaceuticals ALNY:US $ 264.31M 39.49M
Amarin AMRN:US $ 89.88M 4.56M
Amgen AMGN:US $ 6.65B 58M
Arrowhead Research ARWR:US $ 32.41M 119.39M
AstraZeneca AZN:LN USD 10.98B 211M
Biogen BIIB:US $ 2.51B 80.6M
Bluebird Bio BLUE:US $ 71K 1.45M
Bristol Myers Squibb BMY:US $ 11.22B 669M
Eli Lilly And LLY:US $ 6.94B 453.6M
Enanta Pharmaceuticals ENTA:US $ 19.48M 763K
Esperion Therapeutics ESPR:US $ 18.98M 139K
Gilead Sciences GILD:US $ 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Intercept Pharmaceuticals ICPT:US $ 77.59M 5.83M
Moderna Inc MRNA:US 3.36B 1.38B
Neurocrine Biosciences NBIX:US $ 387.9M 9.7M
Novartis NOVN:VX SF 12.67B 412.51M
Ptc Therapeutics PTCT:US $ 217.13M 51.6M
Regeneron Pharmaceuticals REGN:US $ 2.94B 79M
Sangamo Biosciences SGMO:US $ 26.46M 2.92M
Sarepta Therapeutics SRPT:US $ 230.27M 3.22M
Vertex Pharmaceuticals VRTX:US $ 2.33B 138.1M
YTE INCY:US $ 823.3M 88.09M